Clinical Trial Update: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on intravesical photodynamic therapy for non-muscle invasive bladder cancer patients unresponsive or intolerant to BCG; recruitmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Intravesical Photodynamic Therapy (PDT) using Theralase photosensitizer

Snippet

Sponsor: Theralase® Technologies Inc. | Conditions: Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG | Phase 2 | Status: RECRUITING